Nitric oxide therapies in vascular diseases.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Current pharmaceutical design

• Publication date

  2002-01-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1381612023396429PMID 11812265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus

  2001cited by this paper
• Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.

  2001cited by this paper
• Does vitamin E decrease heart attack risk? summary and implications with respect to dietary recommendations.

  2001cited by this paper
• Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance

  2001cited by this paper
• Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling.

  2001cited by this paper
• Nitric oxide in the pathogenesis of vascular disease

  2000cited by this paper
• Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women.

  2000cited by this paper
• Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences

  2000cited by this paper
• Homocysteine and cardiovascular disease: cause or effect?

  2000cited by this paper
• Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice

  2000cited by this paper
• Ascorbic Acid Enhances Endothelial Nitric-oxide Synthase Activity by Increasing Intracellular Tetrahydrobiopterin*

  2000cited by this paper
• Therapeutic potential of vitamin E in heart disease

  2000cited by this paper
• Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes

  2000cited by this paper
• Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension.

  2000cited by this paper
• How does ascorbic acid prevent endothelial dysfunction?

  2000cited by this paper
• Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation.

  2000cited by this paper
• Reverse correlation between urine nitric oxide metabolites and insulin resistance in patients with type 2 diabetes mellitus.

  2000cited by this paper
• Adverse endothelial function and the insulin resistance syndrome

  2000cited by this paper
• Nitric oxide decreases insulin resistance induced by high-fructose feeding.

  2000cited by this paper
• Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.

  2000cited by this paper
• Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans.

  2000cited by this paper
• Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.

  2000cited by this paper
• LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases.

  2000cited by this paper
• Role of L‐arginine in the vascular actions and development of tolerance to nitroglycerin

  2000cited by this paper
• Does ADMA cause endothelial dysfunction?

  2000cited by this paper
• Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E).

  2000cited by this paper
• Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta.

  2000cited by this paper
• Effects of prenylated flavonoids and biflavonoids on lipopolysaccharide-induced nitric oxide production from the mouse macrophage cell line RAW 264.7.

  2000cited by this paper
• Diabetic dyslipidaemia and coronary heart disease: new perspectives.

  1999cited by this paper
• Vitamin E and vascular homeostasis: implications for atherosclerosis

  1999cited by this paper
• Current trends in the development of nitric oxide donors.

  1999cited by this paper
• The effect of red wine on experimental atherosclerosis: lipid-independent protection.

  1999cited by this paper
• Tocotrienol: a review of its therapeutic potential.

  1999cited by this paper
• Plasma polyphenols and antioxidants, oxidative DNA damage and endothelial function in a diet and wine intervention study in humans.

  1999cited by this paper
• Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.

  1999cited by this paper
• Role of dietary lysine, methionine, and arginine in the regulation of hypercholesterolemia in rabbits.

  1999cited by this paper
• Antiatherosclerotic activity of drugs in relation to nitric oxide function.

  1999cited by this paper
• Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR).

  1999cited by this paper
• Dioclein, a new nitric oxide- and endothelium-dependent vasodilator flavonoid.

  1999cited by this paper
• Nitric oxide production is reduced in patients with chronic renal failure.

  1999cited by this paper
• Feeding the nitric oxide synthase inhibitor L-N(omega)nitroarginine elevates serum very low density lipoprotein and hepatic triglyceride synthesis in rats.

  1999cited by this paper
• Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships.

  1999cited by this paper
• Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease.

  1999cited by this paper
• Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion.

  1999cited by this paper
• Endothelial no release caused by red wine polyphenols.

  1999cited by this paper
• Nitric oxide metabolism and breakdown.

  1999cited by this paper
• Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.

  1999cited by this paper
• Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

  1998cited by this paper
• Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.

  1998cited by this paper
• Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure.

  1998cited by this paper
• Procyanidins extracted from pine bark protect α‐tocopherol in ECV 304 endothelial cells challenged by activated RAW 264.7 macrophages: role of nitric oxide and peroxynitrite

  1998cited by this paper
• Hypocholesterolemic properties of nitric oxide. In vivo and in vitro studies using nitric oxide donors.

  1998cited by this paper
• Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits.

  1998cited by this paper
• Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes.

  1998cited by this paper
• Probucol improves endothelial-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits.

  1998cited by this paper
• Nitric oxide and hypercholesterolemia: a matter of oxidation and reduction?

  1998cited by this paper
• Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit.

  1998cited by this paper
• Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans.

  1997cited by this paper
• L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice.

  1997cited by this paper
• Plasma nitrite/nitrate level is inversely correlated with plasma low‐density lipoprotein cholesterol level

  1997cited by this paper
• Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM

  1997cited by this paper
• Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

  1997cited by this paper
• Antioxidants and atherosclerotic heart disease.

  1997cited by this paper
• Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin.

  1997cited by this paper
• Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.

  1997cited by this paper
• Clinical evaluation of probucol in hypercholesteremia: individual lipoprotein responses and inhibitory effect on carotid atherosclerosis progression.

  1997cited by this paper
• Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension.

  1997cited by this paper
• A Caveolar Complex between the Cationic Amino Acid Transporter 1 and Endothelial Nitric-oxide Synthase May Explain the “Arginine Paradox”*

  1997cited by this paper
• Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women.

  1997cited by this paper
• Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

  1997cited by this paper
• The role of antioxidants in preventive cardiology.

  1997cited by this paper
• Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients.

  1997cited by this paper
• Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia.

  1997cited by this paper
• Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis.

  1996cited by this paper
• S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control

  1996cited by this paper
• S‐Adenosylmetliionine and methylation

  1996cited by this paper
• Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.

  1996cited by this paper
• Feeding rats the nitric oxide synthase inhibitor, L-N(omega)nitroarginine, elevates serum triglyceride and cholesterol and lowers hepatic fatty acid oxidation.

  1996cited by this paper
• Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Action of probucol in arteries from normal and hypercholesterolaemic rabbits

  1996cited by this paper
• Oxidized lipoproteins and nitric oxide

  1996cited by this paper
• Amelioration by L‐Arginine of a Dysfunctional Arginine/Nitric Oxide Pathway in Diabetic Endothelium

  1995cited by this paper
• Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study.

  1995cited by this paper
• Dietary nitroprusside alleviates atherosclerosis in hypercholesterolemic Japanese quail (Coturnix coturnix japonica).

  1995cited by this paper
• Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.

  1995cited by this paper
• Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production.

  1995cited by this paper
• Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.

  1995cited by this paper
• Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal Women

  1994cited by this paper
• Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits.

  1994cited by this paper
• Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells.

  1994cited by this paper
• Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure.

  1994cited by this paper
• Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation.

  1994cited by this paper
• Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.

  1994cited by this paper
• The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST).

  1994cited by this paper
• Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.

  1993cited by this paper
• Effect of Increased Availability of Endothelium‐Derived Nitric Oxide Precursor on Endothelium‐Dependent Vascular Relaxation in Normal Subjects and in Patients With Essential Hypertension

  1993cited by this paper
• Hypercholesterolemia increases endothelial superoxide anion production.

  1993cited by this paper
• Role of Endothelium‐Derived Nitric Oxide in the Abnormal Endothelium‐Dependent Vascular Relaxation of Patients With Essential Hypertension

  1993cited by this paper
• Regional and cardiac haemodynamic effects of NG, NG,dimethyl‐l‐arginne and their reversibility by vasodilators in conscious rats

  1993cited by this paper
• Inhibition of human LDL oxidation by resveratrol.

  1993cited by this paper

• Microvascular Dysfunction Following Cardioplegic Arrest and Cardiopulmonary Bypass: Impacts of Diabetes and Hypertension

  2025cites this paper
• Endothelial dysfunction in chronic kidney disease: Mechanisms, biomarkers, diagnostics, and therapeutic strategies

  2025cites this paper
• Light-Armed Nitric Oxide-Releasing Micromotor In Vivo.

  2024cites this paper
• 3-Demethyl-2-geranyl-4-prenylbellidifoline, a natural xanthone with diuretic and kidney protective properties.

  2024cites this paper
• Minimalist Nanocomplex with Dual Regulation of Endothelial Function and Inflammation for Targeted Therapy of Inflammatory Vascular Diseases.

  2023cites this paper
• Vascular Expression of Hemoglobin Alpha in Antarctic Icefish Vascular Expression of Hemoglobin Alpha in Antarctic Icefish Supports Iron Limitation as Novel Evolutionary Driver Supports Iron Limitation as Novel Evolutionary Driver

  2023cites this paper
• Endothelial thioredoxin interacting protein (TXNIP) modulates endothelium-dependent vasorelaxation in hyperglycemia.

  2022cites this paper
• Prolonged Diuretic and Renoprotective Effects of a Xanthone Obtained from Garcinia achachairu Rusby in Normotensive and Hypertensive Rats

  2021cites this paper
• Statins and Peripheral Arterial Disease: A Narrative Review

  2021cites this paper
• L-Arginine/Nitric Oxide Pathway and KCa Channels in Endothelial Cells: A Mini-Review

  2020cites this paper
• L-Arginine Supplementation Improves Vascular Endothelial Dysfunction Induced by High-Fat Diet in Rats Exposed to Hypoxia

  2020cites this paper
• Vascular Expression of Hemoglobin Alpha in Antarctic Icefish Supports Iron Limitation as Novel Evolutionary Driver

  2019cites this paper
• Dietary ginger and turmeric rhizomes prevent oxidative stress and restore delta-aminolevulinic acid dehydratase activity in L-NAME treated rats

  2018cites this paper
• Prolonged diuretic and saluretic effect of nothofagin isolated from Leandra dasytricha (A. Gray) Cogn. leaves in normotensive and hypertensive rats: Role of antioxidant system and renal protection.

  2018cites this paper
• Chicoric acid is a potent anti-atherosclerotic ingredient by anti-oxidant action and anti-inflammation capacity

  2017cites this paper
• Protection against vascular endothelial dysfunction by polyphenols in sea buckthorn berries in rats with hyperlipidemia.

  2016cites this paper
• Impaired vascular function in sepsis-surviving rats mediated by oxidative stress and Rho-Kinase pathway

  2016cites this paper
• Ergothioneine represses inflammation and dysfunction in human endothelial cells exposed to oxidized low-density lipoprotein.

  2015cites this paper
• High fat diet exacerbates vascular endothelial dysfunction in rats exposed to continuous hypobaric hypoxia.

  2015cites this paper
• Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus

  2015cites this paper
• and Obesity: Targets and Therapy

  2015cites this paper
• Vasoactive Properties of an Extract of Allium Sativum in the Rat Aorta

  2015cites this paper
• Serum Uric Acid Levels and Endothelial Dysfunction in Patients with Autosomal Dominant Polycystic Kidney Disease

  2013cites this paper
• Endothelial dysfunction in morbid obesity.

  2013cites this paper
• The effects of atorvastatin on oxidative stress in L-NAME-treated rats

  2013cites this paper
• Asymmetric Dimethyloarginin (ADMA) Concentration in the Aqueous Humor of Patients with Exfoliation Syndrome or Exfoliative Glaucoma

  2013cites this paper
• The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease☆

  2013cites this paper
• Impaired Vasodilation in the Pathogenesis of Hypertension: Focus on Nitric Oxide, Endothelial‐Derived Hyperpolarizing Factors, and Prostaglandins

  2012cites this paper
• The effect of metformin and exercise on serum lipids, nitric oxide synthase and liver nitric oxide levels in streptozotocin-nicotinamide induced diabetic rats

  2012cites this paper
• Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus

  2011cites this paper
• adiponectin, and selectin level in patients with type 2 diabetes mellitus

  2011cites this paper
• NO levels in diabetes mellitus: Effects of l-NAME and insulin on LCAT, Na(+)/K(+) ATPase activity and lipid profile.

  2011cites this paper
• Reprinted article "A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery".

  2011cites this paper
• Plasma Asymmetric Dimethylarginine and Nitric Oxide Levels on Early Prognosis in Patients with Myocardial Infarction Miyokard İnfarktüslü Hastalarda Plazma Asimetrik Dimetil Arginin ve Nitrik Oksit Düzeylerinin Erken Prognoza Etkisi

  2011cites this paper
• Procédés et compositions pour réduire le stress oxydatif

  2010cites this paper
• Multi-ligand nanoparticles for targeted drug delivery to the injured vascular wall

  2010cites this paper
• Preoperative Cardiac Risk Assessment and Management of Elderly Men with an Abdominal Aortic Aneurysm

  2010cites this paper
• Possible reduction of cardiovascular risk in the elderly: prevention of post-prandial hyperglycaemic “spikes” by acarbose

  2010cites this paper
• The Gender Differences in Baseline Characteristics and Statin Intervention Among Outpatients with Coronary Heart Disease in China: The China Cholesterol Education Program

  2009cites this paper
• Crude extracts of Solanum lyratum protect endothelial cells against oxidized low-density lipoprotein-induced injury by direct antioxidant action.

  2009cites this paper
• Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disorders.

  2009cites this paper
• 7-Difluoromethyl-5,4'-dimethoxygenistein inhibits oxidative stress induced adhesion between endothelial cells and monocytes via NF-kappaB.

  2009cites this paper
• Statins: Newer Roles Including Lipid Lowering Therapy

  2009cites this paper
• 7‐difluoromethyl‐5,4′‐dimethoxygenistein, a novel agent protecting against vascular endothelial injury caused by oxidative stress

  2009cites this paper
• Endothelin-1 and H2O2-induced Signaling in Vascular Smooth Muscle

  2009cites this paper
• Exogenous l-Arginine Ameliorates Angiotensin II–Induced Hypertension and Renal Damage in Rats

  2008cites this paper
• Role of oxidative stress in the development of vascular injury and its therapeutic intervention by nifedipine.

  2008cites this paper
• A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients.

  2008cites this paper
• Preparation of the cardiac patient for noncardiac surgery.

  2007cites this paper
• Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway.

  2007cites this paper
• Potential Utility of Combination Therapy with Nateglinide and Telmisartan for Metabolic Derangements in Zucker Fatty Rats

  2007cites this paper
• Functional significance of hsp90 complexes with NOS and sGC in endothelial cells

  2007cites this paper
• Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH.

  2007cites this paper
• Role of postprandial hyperglycaemia in cardiovascular disease in diabetes

  2007cites this paper
• Elastokines et angiogenése : rôle de la MT1-MMP et signalisation intracellulaire mediée par S-GAL

  2007cites this paper
• Etude des mécanismes de revascularisation postischémique chez le rat : Effets de deux puissants vasodilatateurs, le sildenafil et les polyphenols végétaux

  2007cites this paper
• Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level.

  2006cites this paper
• Endothelial dysfunction and impaired L-arginine transport in hypertension and genetically predisposed normotensive subjects.

  2006cites this paper
• Cardiovascular disease in diabetes.

  2006cites this paper
• Pleiotropic effects of nifedipine on atherosclerosis.

  2006cites this paper
• [Endothelial dysfunction: mechanisms of development and therapeutic options].

  2006cites this paper
• The utility of dobutamine stress echocardiography for perioperative and long-term cardiac risk assessment.

  2005cites this paper
• Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

  2005cites this paper
• Regulation of lens aldose reductase activity by nitric oxide.

  2005cites this paper
• Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-κB activity

  2005cites this paper
• Atheroprotective properties of nifedipine.

  2005cites this paper
• Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.

  2005cites this paper
• Molecular mechanisms for vascular injury in the metabolic syndrome.

  2005cites this paper
• Las estatinas como antioxidantes

  2005cites this paper
• Predicting perioperative cardiac risk.

  2005cites this paper
• Antioxidant effects of statins.

  2004cites this paper
• Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention.

  2004cites this paper
• Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

  2004cites this paper
• The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development.

  2004cites this paper
• Perioperative Cardiovascular Risk Stratification and Modification

  2004cites this paper
• Statins in the Primary Prevention of Atherosclerosis-Related Events

  2004cites this paper
• Proteinase-activated Receptor 2 (PAR2): a challenging new target for treatment of vascular diseases.

  2004cites this paper
• Effects of dietary L-arginine supplementation on serum lipids and intestinal enzyme activities in diabetic rats

  2004cites this paper
• Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.

  2004cites this paper
• Simultaneous determination of L-arginine and its mono- and dimethylated metabolites in human plasma by high-performance liquid chromatography–mass spectrometry

  2004cites this paper
• Inhibition of platelet aggregation by polyaspartoyl L-arginine and its mechanism.

  2004cites this paper
• AKT Participates in Endothelial Dysfunction in Hypertension

  2004cites this paper
• Effect of fenofibrate on LDL-induced endothelial dysfunction in rats

  2004cites this paper
• A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery.

  2004cites this paper
• Oxidative stress in essential hypertension.

  2004cites this paper
• Eplerenone, a new selective aldosterone blocker.

  2003cites this paper
• Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial Disease

  2003cites this paper
• Dietary fats, carbohydrates and vascular disease: Sri Lankan perspectives.

  2003cites this paper
• Human tissue kallikrein: a new bullet for the treatment of ischemia.

  2003cites this paper
• Altered insulin-like growth factor-1 and nitric oxide sensitivities in hypertension contribute to vascular hyperplasia.

  2003cites this paper
• Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery.

  2003cites this paper
• Iron chelator research: past, present, and future.

  2003cites this paper
• Hypertension and angiogenesis.

  2003cites this paper
• Inhibitors of the proteolytic activity of urokinase type plasminogen activator.

  2003cites this paper
• The role of nitric oxide (NO) in control of LHRH release that mediates gonadotropin release and sexual behavior.

  2003cites this paper
• Cardiac risk and perioperative management.

  2003cites this paper
• In the presence of L‐NAME SERCA blockade induces endothelium‐dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors

  2002cites this paper
• and Obesity: Targets and Therapy

  year unknowncites this paper